i) β-diketonate versus β-ketoiminate: the importance of a ferrocenyl moiety on improving the anticancer potency, Allison, M., Wilson, D., Pask, C. M., McGowan, P. C. & Lord, R. M, ChemBioChem 2020, 21(14), 1988-1996
ii) Bis(bipyridine)ruthenium(II) ferrocenyl β‐diketonate complexes: exhibiting nanomolar potency against human cancer cell lines, Allison, M., Caramés-Méndez, P., Pask, C. M., Phillips, R. M., Lord, R. M. & McGowan, P. C, Chem. Eur. J. 2021, 27(11), 3737-3744
iii) Fast, facile and solvent-free dry-melt synthesis of oxovanadium(IV) complexes: Simple design with high potency towards cancerous cells Zegke, M., Spencer, H. L. M. & Lord, R. M., Chem. Eur. J. 2019, 25(53), 12275-12280
iv) Understanding the potential in vitro modes of action of bis(β‐diketonato) oxovanadium(IV) complexes Sergi, B., Bulut, I., Xia, Y., Waller, Z. A. E., Yildizhan, Y., Acilan, C. & Lord, R. M., ChemMedChem 2021, 16(15), 2402-241